ストックスクリーナーアプリを入手
0.451
5.57%
-0.0266
前日終値:
$0.4776
開ける：
$0.4769
24時間の取引高:
268.88K
Relative Volume:
0.67
時価総額：
$11.11M
収益：
$56.04M
当期純損益:
$-20.39M
株価収益率:
-0.1848
EPS:
-2.44
ネットキャッシュフロー:
$-6.84M
1週間 パフォーマンス:
-7.20%
1か月 パフォーマンス:
-15.70%
6か月 パフォーマンス:
-49.25%
1年 パフォーマンス:
-36.48%
1日の値動き範囲:
$0.35
$0.4869
1週間の範囲:
$0.35
$0.51
52週間の値動き範囲:
$0.35
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
名前
Cosmos Health Inc
セクター
電話
312-536-3102
住所
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
COSM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.451 | 11.11M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
668.06 | 83.73B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
275.21 | 53.07B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
136.44 | 33.23B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
68.62 | 8.52B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.21 | 2.75B | 6.55B | 155.22M | -823.13M | 1.71 |
Cosmos Health Inc (COSM) 最新ニュース
Cosmos Holdings stock hits 52-week low at $0.44 - Investing.com India
Cosmos Health CEO acquires $44,999 in stock through debt exchange By Investing.com - Investing.com South Africa
Cosmos Health CEO acquires $44,999 in stock through debt exchange - Investing.com
Cosmos Holdings stock hits 52-week low at $0.46 - Investing.com India
Cosmos health CEO acquires shares worth $65,000 in debt exchange By Investing.com - Investing.com South Africa
Cosmos health CEO acquires shares worth $65,000 in debt exchange - Investing.com
Cosmos Health CEO Acquires Over 130K Shares Through Debt Exchange - TradingView
Cosmos Health Inc. (NASDAQ:COSM) Might Not Be As Mispriced As It Looks After Plunging 31% - Simply Wall St
Cosmos Holdings stock hits 52-week low at $0.46 By Investing.com - Investing.com Canada
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company - ACCESS Newswire
Cosmos Health expands distribution of Avian Influenza kits - MSN
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split - ACCESS Newswire
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - ACCESS Newswire
Can Cosmos Health's Massive 60-Product Launch Transform Its Market Position? - StockTitan
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock By Investing.com - Investing.com Canada
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange Agreement - TradingView
Tuesday 2/25 Insider Buying Report: COSM, SEPN - Nasdaq
Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock - Yahoo Finance
Cosmos Health postpones securities offering By Investing.com - Investing.com South Africa
Cosmos Health postpones securities offering - Investing.com India
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - ACCESS Newswire
Strategic Shift: Cosmos Health Postpones Capital Raise, Prioritizes Annual Report - StockTitan
Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 39.7% in January - Defense World
Cosmos Health advances weight management device to clinical trials - MSN
Cosmos health CEO Grigorios Siokas acquires shares worth $29,999 - MSN
Cosmos Health Inc. (COSM) Expands IP Portfolio with AI-Driven Drug Repurposing Patents - Yahoo Finance
Cosmos Health files patents for cancer treatments By Investing.com - Investing.com Australia
Cosmos Health advances weight management device to clinical trials By Investing.com - Investing.com South Africa
Cosmos Health Enters Final Development Phase of CCX0722 Weight M - WICZ
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market - ACCESS Newswire
Cosmos Health's Novel Weight Loss Device Enters Clinical Phase, Eyes Massive $142B Market Opportunity - StockTitan
Cosmos Health files patents for cancer treatments - Investing.com India
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market - ACCESS Newswire
AI Breakthrough: Cosmos Health's Dual Cancer Patents Could Revolutionize $25B Treatment Market - StockTitan
Cosmos Health Appoints Dimitris Moraitis as Vice President of Strategy & Operations - citybiz
Cosmos Health Strengthens Management Team with the Appointment o - WICZ
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations - ACCESS Newswire
Analyzing Ratios: Cosmos Health Inc (COSM)’s Financial Story Unveiled - The Dwinnex
Cosmos Health secures a 10-year contract with Provident - MSN
Cosmos Health Requests Appeal from the Nasdaq Stock Market - ACCESS Newswire
Cosmos Health Inc (NASDAQ: COSM) Up 32.86% From 52-Week Low; YTD Jumps 4.63% – Here’s What To Do Now - Marketing Sentinel
Cosmos Health secures a 10-year contract with Provident By Investing.com - Investing.com South Africa
Cosmos Health Inc (COSM) 財務データ
収益
当期純利益
現金流量
EPS
Cosmos Health Inc (COSM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Mar 03 '25 |
Buy |
0.49 |
132,572 |
65,000 |
4,029,588 |
| Siokas Grigorios | Chief Executive Officer |
Feb 24 '25 |
Buy |
0.56 |
354,296 |
200,000 |
3,897,016 |
| Siokas Grigorios | Chief Executive Officer |
Jan 30 '25 |
Buy |
0.66 |
51,414 |
34,000 |
4,255,103 |
| Siokas Grigorios | Chief Executive Officer |
Jan 22 '25 |
Buy |
0.77 |
38,900 |
30,000 |
4,203,689 |
| Siokas Grigorios | Chief Executive Officer |
Jan 17 '25 |
Buy |
0.86 |
29,158 |
25,000 |
4,164,789 |
| Siokas Grigorios | Chief Executive Officer |
Jan 16 '25 |
Buy |
0.83 |
47,904 |
40,000 |
4,135,631 |
| Siokas Grigorios | Chief Executive Officer |
Jan 15 '25 |
Buy |
0.80 |
62,500 |
50,000 |
4,087,727 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '25 |
Buy |
0.69 |
87,247 |
60,000 |
4,025,227 |
| Siokas Grigorios | Chief Executive Officer |
Jan 13 '25 |
Buy |
0.61 |
163,666 |
100,000 |
3,937,980 |
| Terzis Georgios | Chief Financial Officer |
Dec 20 '24 |
Buy |
0.58 |
85,778 |
50,000 |
727,263 |
7.41%
0.94%
大文字化:
|
ボリューム (24 時間):